Charles River Laboratories International Inc at Evercore ISI HealthCONx Conference Transcript
Hi, everybody. Thanks for joining us today. I'm Elizabeth Anderson. I'm the health care technology and distribution analyst here at Evercore. And I'm very pleased to be joined by Jim Foster, who is the CEO of Charles River Labs. Just before we get started, I just wanted to point out that there is a separate question panel. So if you have a question that you want me to weave into my questions, feel free to put it there, and I will do that.
On that note, Jim, please take it away.
Thanks, Elizabeth. Just a quick sort of summary of where we're at. We reported a really strong third quarter, up almost 8% with our operating margin almost to 23%, which was a really strong quarter. EPS up almost 40%. We did increase our revenue guidance to 5% to 6%, which we're pleased with. I do want to clarify the fact that, while we're pleased to have COVID-related work, it's only about
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
